Brent Standridge - Chief Operating Officer, Aratana Therapeutics, Inc

As of June 27, 2018


Brent Standridge Net Worth

  • Net worth is estimated to be at least $563.06K
  • Owns at least 99,967 units of Aratana Therapeutics, Inc stock
  • Sold an estimated value of $106.77K in the last 2 years at Aratana Therapeutics, Inc

Brent Standridge Compensation at Aratana Therapeutics, Inc in 2018

  • Earned a $315,000 salary
  • Rewarded $191,751 in stock value and options
  • Received a total compensation of $799,804

Brent Standridge Trading

  • Largest sale of shares was 10,000 units , worth over $61.13K on September 27, 2017
  • In total has made about 5 transactions over 2 years
  • Usually trades in January, with the busiest year in 2017 and 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Brent Standridge Mailing Address

  • Mailing address is C/o Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 KS

Aratana Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Steven St. Peter, M.D. 2018 $528,390 $654,948 $649,006 $247,000 $11,000 $2,090,344
Steven St. Peter, M.D. 2017 $513,000 $1,121,998 $982,434 $213,000 $10,800 $2,841,232
Craig A. Tooman 2018 $360,000 $191,751 $189,953 $110,900 $11,000 $863,604
Craig A. Tooman 2017 $360,000 $245,412 $238,970 $95,100 $10,800 $950,282
Brent Standridge 2018 $315,000 $191,751 $189,953 $92,100 $11,000 $799,804
Brent Standridge 2017 $307,500 $109,072 $106,209 $81,300 $10,800 $614,881
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1509190/000150919019000027/petx-20190419xdef14a.htm

Aratana Therapeutics, Inc Insider Trading

  • The most recent transaction was 3,125 units sold on February 1, 2019 by John C Ayres worth over $13.09K
  • In the last 6 years, insiders at Aratana Therapeutics, Inc sold an estimated value of $68.33M and bought an estimated value of $12.01M
  • The most active traders are StSt, PRESIDENT AND CEO,  Ernst Heinen, Chief Development Officer,  and Julia A Stephanus, CHIEF COMMERCIAL OFFICER
  • Insider trading is most common in June, with the busiest year in 2014

ARATANA THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1